Immuron Ltd has released a press release.
Immuron achieves record half yearly Travelan sales
Filed with ASX ·
6ix hasn’t read this filing yet.
Story so far
Earlier from Immuron
- First Patients Enrolled in Campylobacter Clinical Study
- Immuron achieves record quarterly Travelan sales
- Immuron achieves record monthly Travelan sales
- Immuron Receives TGA GMP Clearance
- Immuron enrols patients in Travelan clinical study
Later from Immuron
- Immuron achieves record Travelan sales
- Travelan to progress to Phase 3 Clinical Trials in the US
- Immuron Travelan sales continued strong growth
- IMM-529 pre-IND FDA filing
- Immuron Travelan record sales globally, Australia and USA
Follow Immuron into a list and get an email when it puts out news.
Follow Immuron